Skip to main content
. 2021 Jan 14;7:613158. doi: 10.3389/fnut.2020.613158

Table 4.

Filet fatty acid (mg/100 g on dry matter basis) composition of barramundi fed control and HI-larvae supplemented diets at the termination of the 6-week trial.

Control 60PBM + HI 75PBM + HI ANOVA P
C10:0 0.78 ± 0.03b 4.81 ± 0.72a 4.31 ± 0.06a 0.00
C12:0 1.02 ± 0.09b 295.03 ± 33.71a 294.63 ± 2.47a 0.00
C13:0 0.60 ± 0.00b 1.02 ± 0.12ab 0.92 ± 0.00a 0.01
C14:0 67.46 ± 0.77b 217.78 ± 21.68a 217.70 ± 1.96a 0.00
C14:1n5 0.97 ± 0.03b 6.43 ± 0.73a 6.73 ± 0.07a 0.00
C15:0 17.76 ± 0.63 19.04 ± 1.78 17.81 ± 0.21 0.67
C15:1 0.00 ± 0.00 0.00 ± 0.00 0.18 ± 0.20 0.42
C16:0 713.65 ± 10.19b 1,253.87 ± 105.68a 1,319.91 ± 13.68a 0.00
C16:1n7 130.78 ± 1.90b 281.81 ± 27.55a 287.55 ± 2.38a 0.00
C17:0 44.02 ± 0.52 46.25 ± 3.97 41.62 ± 0.82 0.43
C17:1 22.70 ± 0.31 27.71 ± 2.80 23.65 ± 1.08 0.18
C18:0 278.21 ± 4.07b 427.36 ± 27.76a 452.18 ± 5.83a 0.00
C18:1cis + trans 859.76 ± 5.73b 2,698.63 ± 240.32a 2,974.63 ± 63.88a 0.00
C18:2 trans 17.50 ± 15.25 7.06 ± 1.52 7.05 ± 0.67 0.65
C18:2 cis 320.82 ± 3.44b 1,169.13 ± 101.94a 1,229.36 ± 17.46a 0.00
C18:3n6 17.51 ± 1.42c 48.60 ± 0.80b 58.10 ± 1.30a 0.00
C18:3n3 55.12 ± 0.38b 215.13 ± 19.68a 216.91 ± 1.96a 0.00
C18:4n3# 17.01 ± 1.06b 44.59 ± 2.66a 44.67 ± 1.21a 0.00
C20:0 8.95 ± 0.22b 17.81 ± 1.00a 18.59 ± 0.21a 0.00
C20:1 36.62 ± 0.38b 119.40 ± 10.53a 115.02 ± 0.97a 0.00
C20:2 8.84 ± 0.03b 16.73 ± 1.26a 17.02 ± 0.26a 0.00
C21:0 4.05 ± 0.18b 6.64 ± 0.45a 6.78 ± 0.15a 0.00
C20:3n6 25.68 ± 0.57b 46.67 ± 3.26a 52.49 ± 0.53a 0.00
C20:4n6 92.29 ± 1.90b 121.96 ± 6.52a 120.73 ± 3.17a 0.00
C20:3n3 4.61 ± 0.09b 6.83 ± 0.52a 6.77 ± 0.33a 0.01
C22:0 3.58 ± 0.03b 7.50 ± 0.46a 7.66 ± 0.27a 0.00
C20:5n3 109.31 ± 1.78 126.12 ± 9.98 113.69 ± 1.31 0.19
C22:1n9 4.03 ± 0.03b 11.61 ± 1.04a 11.85 ± 0.09a 0.00
C22:2 0.00 ± 0.00b 0.93 ± 0.09a 1.00 ± 0.00a 0.00
C23:0 13.39 ± 0.68b 25.64 ± 1.36a 27.84 ± 0.15a 0.00
C22:4n6# 62.67 ± 1.07a 29.39 ± 1.68b 23.40 ± 0.59c 0.00
C22:5n3# 71.50 ± 0.95 82.68 ± 5.44 79.49 ± 1.05 0.12
C24:1 11.81 ± 0.12b 14.76 ± 0.91a 14.72 ± 0.17a 0.01
C22:6n3 683.13 ± 12.43a 447.58 ± 23.47b 377.51 ± 8.64c 0.00
∑SFA 1,153.45 ± 15.14a 2,322.75 ± 197.52a 2,409.95 ± 21.74a 0.00
∑MUFA 1,066.66 ± 8.25b 3,160.35 ± 283.49a 3,434.32 ± 67.55a 0.00
∑PUFA 1,485.98 ± 24.56b 2,363.40 ± 174.89a 2,348.18 ± 34.04a 0.00
∑n-3 940.67 ± 15.92 922.93 ± 61.54 839.03 ± 11.05 0.20
∑n-6 198.15 ± 3.87b 246.63 ± 12.20a 254.72 ± 4.82a 0.01
∑n-3/∑n-6 4.75 ± 0.03a 3.74 ± 0.15b 3.29 ± 0.00c 0.00
Atherogenicity 0.32 ± 0.00b 0.34 ± 0.00a 0.33 ± 0.00ab 0.01
Thrombogenicity 0.27 ± 0.00c 0.33 ± 0.00b 0.34 ± 0.00a 0.00

Different superscript letters within the same row denote significant differences between control vs. 60PBM + HI-fed and 75PBM + HI-fed fish (ordinary one-way ANOVA, followed by Dunnett's multiple-comparisons test, P < 0.05).

HI, Hermetia illucens; PBM, poultry by-product meal; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.